Company Overview and News

0
ASX notches up a positive week as Afterpay Touch rallies

12h theage.com.au
Afterpay Touch was the standout in Australian trading during the week, a five-day stretch where the market managed an overall gain despite ongoing concern about the outlook for global trade.
GXY GALXF TNE EVN CAHPF

0
ASX notches up a positive week as Afterpay Touch rallies

12h smh.com.au
Afterpay Touch was the standout in Australian trading during the week, a five-day stretch where the market managed an overall gain despite ongoing concern about the outlook for global trade.
GXY GALXF TNE EVN CAHPF

0
Global X Lithium ETF: Is The 20% Drop Warranted?

2018-07-19 seekingalpha
The Global X Lithium ETF (LIT), which consists of lithium miners and lithium-ion battery manufacturers, has been a favorite among investors looking to get exposure to electric vehicles and energy storage. After a stellar 2017, the ETF has given back some of its earlier gains. LIT is down 20% from its early January high.
SSDIY GALXF GXY MS.PRI MS.PRK 6674 MS.PRE MS.PRF MS.PRG MS MS.PRA GYUAF

1
Will The Lithium Boom Upend The Potash Market?

2018-07-13 seekingalpha
Lithium production from South-American salars (salt flats) is expected to soar, as miners rush to develop new projects.
MOS LACDF WMLLF ERMAF IPI GXY GALXF AVLIF LSSCF NTR WML OROCF MLNLF LAC

1
ASX starts the week higher, shrugging off tariff concerns

2018-07-09 theage.com.au
The Australian sharemarket has begun the week modestly higher as markets across Asia shrugged off trade tariff concerns.
PILBF BLT MS.PRE MS.PRF MS.PRG RDSB IGO RDSA MS.PRA IFGNF GALXF MS RYDAF PLS RDS.B RDS.A IDX BHPBF IFN IIDDY GXY MS.PRI BHP MS.PRK RYDBF BBL BHP BHPLF

1
ASX starts the week higher, shrugging off tariff concerns

2018-07-09 smh.com.au
The Australian sharemarket has begun the week modestly higher as markets across Asia shrugged off trade tariff concerns.
PILBF BLT MS.PRE MS.PRF MS.PRG RDSB IGO RDSA MS.PRA IFGNF GALXF MS RYDAF PLS RDS.B RDS.A IDX BHPBF IFN IIDDY GXY MS.PRI BHP MS.PRK RYDBF BBL BHP BHPLF

2
Australian shares advance on strength of major banks

2018-07-03 theage.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG MS.PRE MS.PRF MS.PRG MS.PRA BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF MS.PRI BHP RIO MS.PRK BBL BHP BHPLF EBO

2
Australian shares advance on strength of major banks

2018-07-03 smh.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG MS.PRE MS.PRF MS.PRG MS.PRA BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF MS.PRI BHP RIO MS.PRK BBL BHP BHPLF EBO

102
Lithium's Top Challenge Is Finding Funds, Not the Battery Metal - Bloomberg

2018-07-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PILBF C.WSA BNPQY MS.PRE MS.PRF MS.PRG 2333 MS.PRA NMKEF C.WS.B GALXF ALTAF NMX C.WS.A C.PRP C.PRU MS C.PRS PLS KDR C C.PRL NHPEF C.PRJ C.PRK BNPQF C.PRG C.PRC VLKAF BNPZY GXY MS.PRI C.PRPCL MS.PRK CGBBW AJM

14
Dempsey Minerals sky high as it pursues lithium strategy in Argentina

2018-06-29 proactiveinvestors.com.au
Dempsey Minerals Ltd (ASX:DMI) is riding the lithium wave with its primary focus on the prolific Lithium Triangle area of Argentina and shares reflect the strategy.
GXY GALXF FTI.WI FMC DMI SQM

1
Galaxy strengthens Mt Cattlin presence with acquisition

2018-06-24 australianmining.com.au
Galaxy Resources has added lithium tenements at Mt Cattlin in Western Australia through the acquisition of assets owned by Kingston Resources.
KSN GXY GALXF

140
It's Electric: Key Growth Investing Trends To Watch

2018-06-19 seekingalpha
Electric vehicles have a long road ahead of them, even if Tesla sees a few twists and turns along the way.
PILBF SSNLF CCZ RNSDF HAV GALXF ALTAF GM.WS.A GM.WS.B GM.WS.C GM VLKAY PLS AYR BC94 SMSN BSWQY DDAIF TWNAF KATFF GXY KAT TAW GOOGL MU GM.WSB AJM SMSD

2
Commonwealth Bank leads ASX despite $700m penalty

2018-06-04 theage.com.au
The Australian share market has rallied from losses made last week to close the day higher, led by the Commonwealth Bank of Australia.
AGLNY GXY GALXF JBHHY AGLNF JBH

2
Commonwealth Bank leads ASX despite $700m penalty

2018-06-04 smh.com.au
The Australian share market has rallied from losses made last week to close the day higher, led by the Commonwealth Bank of Australia.
AGLNY GXY GALXF JBHHY AGLNF JBH

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...